GlaxoSmithKline PLC Director/PDMR Shareholding (0324Q)
14 Febrero 2019 - 4:33AM
UK Regulatory
TIDMGSK
RNS Number : 0324Q
GlaxoSmithKline PLC
14 February 2019
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
======================================================================
a) Name Mrs V A Whyte
=== ======================== ============================================
b) Position/status SVP & Company Secretary
=== ======================== ============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ======================================================================
a) Name GlaxoSmithKline plc
=== ======================== ============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ======================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ======================== ============================================
b) Nature of the Award of Ordinary Shares under the Company's
transaction 2009 Share Value Plan
=== ======================== ============================================
c) Price(s) and Price(s) Volume(s)
volume(s) GBP15.47 3,020
----------
=== ======================== ============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ============================================
e) Date of the transaction 2019-02-13
=== ======================== ============================================
f) Place of the n/a
transaction
=== ======================== ============================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBZLFFKLFXBBL
(END) Dow Jones Newswires
February 14, 2019 05:33 ET (10:33 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024